Journals / Medical Network Klinik Bilimler ve Doktor / 2002 / Cilt: 8 - Sayı: 2

Antithrombin-III levels and prognostic importance in neonatal sepsis

Yenidoğan sepsisinde antitrombin-III düzeyleri ve prognostik önemi

Pages
203–207
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Significantly low AT-III levels in septic shock and/or DIC than in those with only sepsis, and in neonates that died than the levels in those that survived suggest that AT-III levels may be of prognostic importance in neonatal sepsis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: We invastigated plasma Antithrombin-III (AT-III) levels and its prognostic importance in neonatal sepsis.
📊
Key Findings & Data:MATERIAL AND METHODS: Thirtyfour term neonates with sepsis and 34 healthy term neonates were investigated in this study.
💡
Conclusion & Impact:CONCLUSION: Significantly low AT-III levels in septic shock and/or DIC than in those with only sepsis, and in neonates that died than the levels in those that survived suggest that AT-III levels may be of prognostic importance in neonatal sepsis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sepsis · Süt çocuğu · yenidoğan

Abstract

AIM: We invastigated plasma Antithrombin-III (AT-III) levels and its prognostic importance in neonatal sepsis. MATERIAL AND METHODS: Thirtyfour term neonates with sepsis and 34 healthy term neonates were investigated in this study. In the sepsis group, 15 (44.1%) neonates developed septic shock, and 12 (35.3%) developed Disseminated Intravascular Coagulation (DIC), supported by clinical and laboratory findings. Sixteen patients (47.1%) were diagnosed as septicemia, without clinically manifest DIC. Hematologic parameters, C-reactive protein, sedimantation rate, liver function tests, coagulation tests (prothrombin time,activated partial thromboplastin time, fibrinogen level, bleeding and clotting time) and Antithrombin-III (AT-III) levels were evaluated during the clinical course. AT-III, independent from vitamin K, is one of the natural inhibitors of the coagulation system, secreted in hepatocytes. RESULTS: Mean AT-III level in the sepsis group was significantly lower than that of the control group (13.1±4.46 mg/dl vs 21.8±3.6 mg/dl)(p<0.01). AT-III levels of the patients with septic shock and/or DIC were much lower (p<0.001). Mortality rates in only sepsis, septic shock and DIC subgroups were; 18.7%, 60.0% and 83.3% respectively. AT-III levels of the neonates who died were significantly lower, compared to those that survived (p<0.001). CONCLUSION: Significantly low AT-III levels in septic shock and/or DIC than in those with only sepsis, and in neonates that died than the levels in those that survived suggest that AT-III levels may be of prognostic importance in neonatal sepsis.

Özet

AMAÇ: Yenidoğan sepsisinde, plazma antitrombin-III düzeylerinin prognozla ilişkisini araştırmayı planladık. GEREÇ VE YÖNTEM: Çalışmada 34 miyadında sepsisli yenidoğan ve 34 miyadında sağlıklı yenidoğan incelendi. Hastaların 15 (%44.1)'inde septik şok, 12 (%35.3)'sinde de klinik ve laboratuvar bulguları ile desteklenen Dissemine İntravasküler Koagulasyon (DİK) tablosu gelişti. Onaltı (%47.1) hasta ise septik şok ve DİK kliniği gelişmeksizin yalnızca septisemi tanısı ile izlendi. Bu hastaların klinik gidişi izlenirken, hematolojik parametreleri, C-reaktif protein, sedimantasyon hızı, karaciğer fonksiyon testleri, koagulasyon testleri (ptotrombin zamanı, aktive parsiyel tromboplastin zamanı, fibrinojen düzeyi, kanama ve pıhtılaşma zamanı) ve anti-trombin-III düzeyleri değerlendirildi. AT-III, K vitamininden bağımsız, hepatositlerde sentezlenen koagulasyon sisteminin doğal inhibitörlerinden biridir. BULGULAR: Çalışmaya alınan 34 sepsisli yenidoğanın AT-III düzeyleri ortalaması 13.1±4.46 mg/dl, kontrol grubunda ise 21.8±3.6 mg/dl olarak saptandı. Sepsisli hastalarda AT-III düzeyleri anlamlı olarak düşük idi (p 0.001). Yalnız sepsis, septik şok ve DİK gelişen hastalarda ölüm oranları sırasıyla %18.7, %60.0 ve %83.3 olarak bulundu. Ölen yenidoğanların AT-III düzeyleri yaşayanlarla karşılaştırıldığında anlamlı olarak düşük bulundu (p<0.001). SONUÇ: Septik şok ve/veya DİK gelişen hastalarda, yalnız sepsisli olan hastalara ve ölen hastalarda yaşayanlara göre AT-III düzeylerinin belirgin düşük olması, yenidoğan sepsisinde AT-III düzeylerinin prognostik önemi olabileceğini göstermektedir.

🔖

Cite This Article

ALTINÖZ, S., ERSOY, B., NEHİR, H., AYDOĞAN, A., TANSUĞ, N. (2002). Antithrombin-III levels and prognostic importance in neonatal sepsis. Medical Network Klinik Bilimler ve Doktor, Cilt: 8 - Sayı: 2, 203–207. https://ajindex.com/articles/279178

References (9)

  1. Montgomery RR, Scott JP. Hemostasis: Diseases of Coagulation: The Fluid Phase. In: Nathan DG, Oski FA (ed). Hematology of Infancy and Childhood.(4th ed) WB Saunders Company 1992; 1605-50.
  2. Mortensen JZ, Jorgensen KA: Antithrobin HI. A review. Dan Med Bull 1983; 30: 100-5.
  3. Montgomery RR, Scott JP. Hemorrhagic and Thrombotic Diseases In: Behrman RE, Kleigman RM, Jenson HB (ed). Texbook of Pediatrics. (16th ed.) WB Saunders Company 2000; 1504-25. Hathaway WE. Clinical aspects of Antithrobin-IU deficiency. Hematology 1991; 28:19-23.
  4. Andrew M, Brooker LA. Hemostatic Disorders in Newborns In: Taeush HW, Ballard RA (ed). Avery's Diseases of the Newborn. (7th ed) WB Saunders Comp, 1998; 1045-79: Siegel JD. Sepsis Neonatorum In: Oski FA, De Angelis CD, Feigin Rd, Me Millan JA, Warshaw, JB (ed). Principles and Practice of Pediatrics. JP Lippencott Comp. Philadelphia, 1994: 516-25.
  5. Feigin RD, Adcock LM, Miller DJ. Postnatal bacterial infections. In: Fanaroff AA, Martin RJ (ed). Neonatal-Perinatal Medicine, diseases of the fetus and infant. (5th ed) Mosby Year Book 1992; 619-61. Powell KR. Sepsis and Shopk. In: Behrman RE, Kleigman RM, Jenson HB.(ed) Texbook of Pediatrics. (16th ed) WB Saunders Company 2000; 747-51. Thijs LD, de Boer JP, de Groot MCM, Hack CE. Coagulation discorders in septic shock. Intensive Care Med 1983; 19:S8-S15. Hack JE. Inhibitor substition in sepsis. Intensive Care Med 1993; 19: S1-S2. Mammen EF. Perspectives for the future. Intensive Care Med 1993; 19 Suppl 1P.-S29-S34. Küçüködük Ş. Sepsis. In.Küçüködük Ş (ed) Yenidoğan ve Hastalıkları, 1994, 607-15. Lucens JN. Blood formation in the embryo, fetus and newborn. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lucens JN (ed) Wintrobe's Clinical Hematology. (9 th ed.) Lea & Febiger, 1993; 79-94.
  6. Segal GB, Oski FA. Hematology of the newborn. In: Williams WJ, Beutler E, Erslev AJ, Lichthman MA (ed). Hematology (4 th ed) Me Graw-Hill Publish Company 1991; 100-9.
  7. Massgnon D, Lepape A, Bienvenu J, Barbier Y, Boileau C, Caeur P. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 1994; 24:36-48.
  8. Roman J, Velasco F, Fernandez F, Fernandez M, Vilalba R, Rubio V, Vicente A, Torres A. Coagulation, fibrinolytic and kallikrein systems in neonates with uncoplicated sepsis and septic shock. Haemostasis 1993; 23:142-8.
  9. Dofferhoff ASM, De jong HJ, Bom VJJ. Complement activation and the production of imflammatory mediators during the treatment of severe sepsis in h